SCHEMBL1198152

SCHEMBL1198152

CCNC1CCNCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL6629106 0.97 KCNH2 (0.71)
SCHEMBL19121999 0.91 KCNH2 (0.63)
SCHEMBL13766535 0.89 KCNH2 (0.61)
SCHEMBL1782773 0.85
SCHEMBL1781000 0.85
SCHEMBL2012943 0.85
Hydrochloric Acid SCHEMBL7007471 0.83 KCNH2 (0.95)
Hydrochloric Acid SCHEMBL15668022 0.83 KCNH2 (0.95)
Hydrochloric Acid SCHEMBL15668025 0.83 KCNH2 (0.95)
Pyrimidine SCHEMBL7658961 0.82 KCNH2 (0.53)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 551 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3567041-B1 SUBSTITUTED FUSED HETEROARYL COMPOUND SERVING AS A KINASE INHIBITOR, AND APPLICATIONS THEREOF IMPACT THERAPEUTICS SHANGHAI INC (CN) 2023-12-27 EP claimed
CN-114787162-A Substituted imidazoquinoxaline compounds and uses thereof 上海瑛派药业有限公司 2022-07-22 CN claimed
CN-106883232-B A kind of derivative and the preparation method and application thereof of non-that alkene -3- ketone of azepine 苏州康润医药有限公司 2019-01-22 CN claimed
CN-106883232-A A kind of derivative of non-that ketone of alkene 3 of azepine and preparation method and application 苏州康润医药有限公司 2017-06-23 CN claimed
US-4147696-A VULCANIZATION ACCELERATORS SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1979-04-03 US claimed
US-20250333418-A1 PURINE COMPOUNDS, COMPOSITIONS COMPRISING THEM AND USES THEREOF NOVO NORDISK AS (DK) 2025-10-30 US disclosed
US-20250213735-A1 NEUROPEPTIDE Y1 RECEPTOR (NPY1R) TARGETED THERAPEUTICS AND USES THEREOF RADIONETICS ONCOLOGY, INC. 2025-07-03 US disclosed
CN-119215050-A Application of substituted imidazoquinoxaline compound in preparation of anti-cancer drugs 上海瑛派药业有限公司 2024-12-31 CN disclosed
CN-119080781-A Substituted imidazoquinoxaline compounds and uses thereof 上海瑛派药业有限公司 2024-12-06 CN disclosed
CN-118834313-A Zwitterionic polymer, ion exchange membrane, and preparation methods and applications thereof 佛山绿动氢能科技有限公司 2024-10-25 CN disclosed
CN-114787162-B Substituted imidazoquinoxaline compounds and uses thereof 上海瑛派药业有限公司 2024-09-03 CN disclosed
CN-115151252-B Iron death inhibitor-diarylamine acetamides 维泰瑞隆有限公司 2024-08-27 CN disclosed
CN-87106838-A Tricyclic compound 1988-05-11 CN disclosed
US-4485020-A FLOW CONTROL AGENTS FOR ENHANCED OIL RECOVERY PHILLIPS PETROLEUM COMPANY (US) 1984-11-27 US disclosed
US-4147696-A VULCANIZATION ACCELERATORS SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1979-04-03 US disclosed
US-4064347-A Bis-basic ketones of fluorene and fluorenone RICHARDSON-MERRELL INC. (US) 1977-12-20 US disclosed
US-4041165-A TREATING DELAYED HYPERSENSITIVITY RICHARDSON-MERRELL INC. (US) 1977-08-09 US disclosed
US-3957989-A ADMINISTERING RICHARDSON-MERRELL INC. (US) 1976-05-18 US disclosed
US-3957988-A Antiviral compositions containing bis-basic ketones of thioxanthene RICHARDSON-MERRELL INC. (US) 1976-05-18 US disclosed
US-3937833-A DELAYED HYPERSENSITIVITY RICHARDSON-MERRELL INC. (US) 1976-02-10 US disclosed